Axsome TherapeuticsAXSM +1.83%52 Days Inventory is 184.21 as of Mar. 2026, which is 9% above its 10-year median of 168.51. GuruFocus rates AXSM with a GF Score™ of 52/100 and a GF Value™ of $220.41 (Fairly Valued). The stock has 4 warning signs investors should review. Among 640 Biotechnology companies, Axsome Therapeutics ranks better than 55.62% on this metric.
The historical rank and industry rank for Axsome Therapeutics's Days Inventory or its related term are showing as below:
AXSM'
s Days Inventory Range Over the Past 10 Years
Min: 136.22 Med: 168.51 Max: 303.35
Current: 164.33
During the past 13 years, Axsome Therapeutics's highest Days Inventory was 303.35. The lowest was 136.22. And the median was 168.51.
AXSM's Days Inventory is ranked better than 55.62% of 640
companies
in the Biotechnology industry
Industry Median: 184.145
vs AXSM: 164.33
Axsome Therapeutics's Days Inventory
increased
from Mar. 2025 (149.38) to Mar. 2026 (184.21).
It might indicate that Axsome Therapeutics's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Axsome Therapeutics's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.50.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Axsome Therapeutics's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.16.
Axsome Therapeutics (NAS:AXSM) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Axsome Therapeutics's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Axsome Therapeutics's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Axsome Therapeutics Days Inventory Related Terms
Axsome Therapeutics Days Inventory Historical Data
* Premium members only.
The historical data trend for Axsome Therapeutics's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AXSM vs IONS, EXEL, MDGL: Days Inventory Comparison
For the Biotechnology subindustry, Axsome Therapeutics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Axsome Therapeutics Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Axsome Therapeutics's Days Inventory distribution charts can be found below:
* The bar in red indicates where Axsome Therapeutics's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Axsome Therapeutics (AXSM) has a Days Inventory of 184.21 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Axsome Therapeutics and its competitors. This is near median its historical median of 168.51. Over the past decade, Axsome Therapeutics' Days Inventory has ranged from 136.22 to 303.35. According to the industry distribution chart, Axsome Therapeutics ranks #284 out of 640 companies in the Biotechnology industry, placing it in the top 44.4%.
Is Axsome Therapeutics' Days Inventory too high?
Axsome Therapeutics' current Days Inventory of 184.21 is near median its 10-year median of 168.51. Over the past 10 years, this metric has ranged from a low of 136.22 to a high of 303.35. The Biotechnology industry median Days Inventory is 184.15. Axsome Therapeutics' value of 184.21 is 0% above this industry median. Based on the distribution chart, Axsome Therapeutics ranks #284 out of 640 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Axsome Therapeutics has a GF Score™ of 52/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Axsome Therapeutics' Days Inventory compare to IONS and EXEL?
According to the Biotechnology industry distribution chart, Axsome Therapeutics ranks #284 out of 640 companies for Days Inventory. This puts Axsome Therapeutics in the upper half of its industry. The industry median Days Inventory is 184.15. Axsome Therapeutics' value of 184.21 is 0% above this benchmark. Historically, Axsome Therapeutics' own Days Inventory has ranged from 136.22 to 303.35 over the past decade. While the company's 10-year median is 168.51 vs. the industry median of 184.15, Axsome Therapeutics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 184.15, based on 640 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Axsome Therapeutics's current Days Inventory of 184.21 is 0% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Axsome Therapeutics and its competitors. For the Biotechnology industry, the median Days Inventory is 184.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Axsome Therapeutics's current Days Inventory is 184.21, which is near median its own 10-year median of 168.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Axsome Therapeutics stock overvalued right now?
Based on GuruFocus' analysis, Axsome Therapeutics (AXSM) is currently considered Fairly Valued. The stock's GF Value™ is $220.41, compared to a current price of $241.67 — trading 9.6% above its estimated fair value. The current Days Inventory is 184.21, which is near median its 10-year median of 168.51 and 0% above the Biotechnology industry median of 184.15. Axsome Therapeutics' overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Axsome Therapeutics (AXSM), the current Days Inventory is 184.21 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Axsome Therapeutics (AXSM) Overvalued in 2026?
Based on GuruFocus' analysis, Axsome Therapeutics stock appears to be overvalued.
The current stock price of $241.67 is trading 9.6% above its estimated GF Value™ of $220.41.
GuruFocus considers Axsome Therapeutics to be Fairly Valued.
Key valuation signals for AXSM:
Days Inventory: 184.21 (near median its 10-year median of 168.51)
GF Value™: $220.41 vs. price of $241.67 (9.6% above fair value)
Industry Position: 0% above the Biotechnology median (#284 of 640)
No single metric tells the full story. See the AXSM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
52GF Score
Get the complete analysis for AXSM
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AXSM has been successfully added to your 
